Since the ground-breaking ceremony at the end of March 2018, the extension of the business premises of BLS-Analytik GmbH is making great progress. The topping-out ceremony was celebrated at the end of September 2018 and the move in the new building is scheduled for April 2019.
A modern extension with four floors and about 1200 m² is being built in close cooperation with Tentamus CEO Dr. Jochen Zoller and the Technical Director Dr. Cord Lüllmann. The current laboratories will be enlarged by 600 m2on the first two floors. The top floor of the new building will not yet be utilized. This space is designed as an additional area for the administration and allows to extend the laboratories to the third floor.
Currently, various craftsmen are busy with interior work. “Seasonal weather conditions, as well as smaller and larger problems surprise every builder and do not stop in front of a commercial building”, explains Dr. Jochen Kolb, the BLS Analytik managing director with a smile.
Furthermore, a state-of-the-art, “high-potent”, pressurized laboratory with security gate will be located in the new building in order to allow more cytostatic and high-potent drugs analysis. The departments elemental analysis, stability storage and drug release will be expanded. A new, large meeting room is designed for internal and external training and will also provide meeting space for clients.
“We are looking forward to the new space and will definitely get it filled up quickly,” notes Dr. Kolb. The BLS Analytik is already recruiting new employees and plans to gradually increase from current 38 to up to 60 employees in the next years.
About BLS Analytik
BLS-Analytik GmbH is an accredited, officially recognized contract laboratory in the Tentamus Group. The offered services cover the entire range of analysis in the international GMP and ISO-certified field. Already since 1990 physicochemical, analytical testing as well as instrumental analytics have been established. The main field of activity is pharmaceutical analysis of finished medicinal products, pharmaceutical raw materials and excipients according to their registration documents and currently valid monographs. Furthermore, food, consumer goods and cosmetics are analysed.
A modern extension with four floors and about 1200 m² is being built in close cooperation with Tentamus CEO Dr. Jochen Zoller and the Technical Director Dr. Cord Lüllmann. The current laboratories will be enlarged by 600 m2on the first two floors. The top floor of the new building will not yet be utilized. This space is designed as an additional area for the administration and allows to extend the laboratories to the third floor.
Currently, various craftsmen are busy with interior work. “Seasonal weather conditions, as well as smaller and larger problems surprise every builder and do not stop in front of a commercial building”, explains Dr. Jochen Kolb, the BLS Analytik managing director with a smile.
Furthermore, a state-of-the-art, “high-potent”, pressurized laboratory with security gate will be located in the new building in order to allow more cytostatic and high-potent drugs analysis. The departments elemental analysis, stability storage and drug release will be expanded. A new, large meeting room is designed for internal and external training and will also provide meeting space for clients.
“We are looking forward to the new space and will definitely get it filled up quickly,” notes Dr. Kolb. The BLS Analytik is already recruiting new employees and plans to gradually increase from current 38 to up to 60 employees in the next years.
About BLS Analytik
BLS-Analytik GmbH is an accredited, officially recognized contract laboratory in the Tentamus Group. The offered services cover the entire range of analysis in the international GMP and ISO-certified field. Already since 1990 physicochemical, analytical testing as well as instrumental analytics have been established. The main field of activity is pharmaceutical analysis of finished medicinal products, pharmaceutical raw materials and excipients according to their registration documents and currently valid monographs. Furthermore, food, consumer goods and cosmetics are analysed.
